Previous Article | Next Article 
Infection and Immunity, March 2001, p. 1554-1560, Vol. 69, No. 3
0019-9567/01/$04.00+0 DOI: 10.1128/IAI.69.3.1554-1560.2001
Copyright © 2001, American Society for Microbiology. All rights reserved.
Cytokine Networking in Lungs of Immunocompetent Mice in Response
to Inhaled Aspergillus fumigatus
Joan K.
Brieland,1,*
Craig
Jackson,1
Fred
Menzel,1
David
Loebenberg,1
Anthony
Cacciapuoti,1
Judy
Halpern,1
Stephen
Hurst,2
Tony
Muchamuel,2
Reno
Debets,2
Rob
Kastelein,2
Tatyana
Churakova,2
John
Abrams,2
Roberta
Hare,1 and
Anne
O'Garra2
Department of Chemotherapy, Schering Plough
Research Institute, Kenilworth, New Jersey,1
and DNAX Research Institute, Palo Alto,
California2
Received 30 October 2000/Returned for modification 8 December
2000/Accepted 15 December 2000
 |
ABSTRACT |
Cytokine networking in the lung in response to inhaled
Aspergillus fumigatus was assessed using a murine model of
primary pulmonary aspergillosis in immunocompetent Crl:CF-1 mice.
Inhalation of virulent A. fumigatus (6 × 106 CFU) resulted in the induction of interleukin 18 (IL-18), tumor necrosis factor alpha (TNF-
), IL-12, and
gamma interferon (IFN-
) protein in bronchoalveolar lavage fluid
and/or lung tissue. Induction of immunoreactive IL-18 preceded
induction of TNF-
protein, which preceded induction of
immunoreactive IL-12 and IFN-
. Real-time reverse
transcriptase (RT) PCR analysis of infected lung tissue demonstrated
that induction of IL-18 protein also preceded induction of
pulmonary TNF-
, IL-12, and IFN-
mRNAs. Mice were
subsequently treated with cytokine-specific neutralizing monoclonal
antibodies (MAbs) to the IL-18 receptor (anti-IL-18R MAb),
TNF-
(anti-TNF-
MAb), IL-12 (anti-IL-12 MAb),
and/or IFN-
(anti-IFN-
MAb), and effects on
intrapulmonary cytokine activity and growth of A. fumigatus were assessed in infected lung homogenates. Simultaneous neutralization of IL-12 and IL-18 resulted in decreased levels of
immunoreactive TNF-
, while neutralization of IL-18,
TNF-
, or IL-12 alone or of IL-18 and IL-12 together
resulted in decreased levels of immunoreactive IFN-
.
Simultaneous neutralization of IL-12 and IL-18 or
neutralization of TNF-
alone or in combination with IL-12,
IL-18, or IFN-
also resulted in a significant increase in
A. fumigatus CFU in lung tissue. Taken together, these
results demonstrate that endogenous IL-18, IL-12, and
TNF-
, through their modulatory effects on both intrapulmonary
cytokine activity and growth of A. fumigatus, play key
roles in host defense against primary pulmonary aspergillosis.
 |
INTRODUCTION |
Aspergillus fumigatus is
a saprophytic fungus and a causative agent of invasive pulmonary
aspergillosis, a predominant life-threatening opportunistic infection
in immunocompromised patients (16, 50, 51). Host defense
against primary A. fumigatus pulmonary infection is mediated
by phagocytic cells of the innate immune system (11, 15, 25,
38). Alveolar macrophages ingest and kill inhaled Aspergillus conidia, while polymorphonuclear leukocytes
destroy Aspergillus hyphae that germinate from conidia that
have escaped macrophage killing (25, 45, 49).
Polymorphonuclear leukocyte-mediated killing of Aspergillus
hyphae is critical for prevention of hyphal invasion and destruction of
pulmonary tissue (2, 12-14, 25, 44, 45, 49). The
effectiveness of this dual macrophage-neutrophil-mediated host defense
against A. fumigatus is evidenced by the paucity of serious
Aspergillus infections in immunocompetent persons, despite
environmental exposure to the fungus.
Previous studies have demonstrated that T-helper (Th) cytokines
contribute to phagocytic cell-mediated host defense against A. fumigatus. Stimulation of cultured phagocytic cells with Th1 cytokines, including gamma interferon (IFN-
), enhanced
fungicidal activity, while stimulation of similarly cultured cells with
Th2 cytokines, including interleukin 4 (IL-4) and IL-10, had
the opposite effect (15, 37, 41, 42). Similarly, murine
resistance to experimentally induced A. fumigatus infections
was correlated with induction of cytokines, including tumor necrosis
factor alpha (TNF-
), IL-12, and IFN-
, while
susceptibility to infection was associated with the production of
IL-4 and/or IL-10 (6-8, 29). Likewise,
administration of exogenous cytokines, including TNF-
, IL-12, or IFN-
, or neutralization of endogenous IL-4
and/or IL-10 enhanced murine resistance to infection, while
neutralization of endogenous IFN-
and/or TNF-
enhanced
susceptibility to infection (5, 6, 29).
While these studies suggest a directive role of Th1 cytokines in
leukocyte-mediated defense against A. fumigatus infections, the relative contribution of each cytokine to innate immunity in
pulmonary aspergillosis has not been thoroughly investigated. Likewise,
a recently described cytokine, IL-18 (30-32), has
been shown to play a key role in Th1-mediated defense against other pathogens, including Mycobacterium tuberculosis
(46) and Cryptococcus neoformans
(36), likely due, at least in part, to immunomodulatory effects of IL-18 on other cytokines, including TNF-
and
IFN-
(1, 30, 40, 47, 53). The role of endogenous
IL-18 in host resistance to A. fumigatus pulmonary
infection has not been investigated.
In the current study, immunocompetent Crl:CF-1 mice were infected with
aerosolized, virulent A. fumigatus, and the temporal induction of cytokines, including IL-18, TNF-
, IL-12,
and IFN-
, was determined in bronchoalveolar lavage fluid (BALF)
and in lung homogenates by cytokine-specific murine enzyme-linked
immunosorbent assays (ELISAs) and by real-time reverse transcriptase
(RT) PCR. Subsequently, by using cytokine-specific neutralizing
monoclonal antibodies (MAbs), the immunomodulatory role and biological
relevance of each cytokine in host resistance to primary A. fumigatus pulmonary infection were assessed.
 |
MATERIALS AND METHODS |
Mice.
Male specific-pathogen-free outbred immunocompetent
Crl:CF-1 mice (11 to 13 g; Charles River) were used for all
experiments. Animals were housed in microisolator cages and were cared
for in accordance with standard guidelines.
Inhalation model of murine pulmonary aspergillosis.
Mice
were infected with A. fumigatus ATCC 201795 in an
inhalation chamber using a 30-s exposure as previously described
(26, 34). Briefly, the inhalation chamber consisted of a
1-liter Pyrex flask with eight tubular glass side arms, each at a 30° angle from the horizontal and spaced equidistantly around the flask.
Prior to infection, the bottom of the flask was filled with malt agar,
seeded with a suspension of A. fumigatus conidia, and
incubated at 28°C for 13 days to produce a fungal lawn. Mice were
subsequently individually placed in each side arm (eight mice per
flask), pushed to the bottom of the arm (so that the nose filled and
extended beyond the open end of the tube), and held in place by cotton
plugs. The top of the flask was then closed with a rubber stopper,
which was transversed by a glass rod, the end of which extended
directly above the fungal lawn. To generate an aerosol, turbulence was
created over the culture via the forceful expulsion of 60 cm3 of air through the end of the glass rod, using a 60-ml
syringe which was connected to the stoppered end of the glass rod by a piece of plastic tubing. This method resulted in the uniform dispersion of conidia and infection of mice throughout the chamber.
Quantification of A. fumigatus in infected lung
homogenates.
At specific times postinfection (p.i.), mice were
euthanatized and their lungs were excised and homogenized in 10 ml of
sterile phosphate-buffered saline. Lung homogenates from individual
mice were serially diluted on Sabouraud dextrose agar plates and were incubated for 48 h at 30°C prior to quantification of
A. fumigatus CFU. Results are expressed as
log10 CFU per lung.
Collection of lung homogenate supernatant and BALF for cytokine
analysis.
Lung homogenate supernatant was procured by filtering
lung homogenates prepared as described above through a
0.22-µm-pore-size filter (Gelman Sciences, Ann Arbor, Mich.) to
remove bacteria. Alternatively, for collection of BALF, mice were
humanely euthanatized and their lungs were lavaged with 1.6 ml of
phosphate-buffered saline (3). The resultant lavage fluid
was subsequently filtered as described above. Filtered lung homogenates
and BALF were stored at
80°C until use for cytokine analysis.
Cytokine analysis.
Immunoreactive IL-18, IL-12,
TNF-
, and IFN-
protein levels in BALF and/or lung
homogenate supernatants were measured by commercially available
cytokine-specific murine ELISA kits (Quantikine mouse-IL-18, mouse
IL-12p70, mouse TNF-
, and mouse IFN-
; R & D,
Minneapolis, Minn.) according to the manufacturer's directions.
Quantitation of cytokine transcripts by real-time RT-PCR.
Real-time RT-PCR assays were performed to specifically quantify mouse
IL-18, TNF-
, IL-12, and IFN-
transcripts.
Briefly, lungs were excised from A. fumigatus-infected
mice at specific times p.i. and were flash frozen in liquid nitrogen.
Total RNA was extracted using TriReagent (Molecular Research Center,
Cincinnati, Ohio) according to the manufacturer's directions and was
stored at
80°C in nuclease-free water containing 0.1 mM EDTA.
Isolated RNA (5 µg) was incubated with 10 U of DNase I (Boehringer
Mannheim) in the presence of RNasin (Promega) for 30 min at 37°C. The
samples were then heat inactivated at 70°C for 10 min, chilled, and
reverse transcribed with Superscript II RT (Gibco/BRL) with 1 µg each of random hexamers and oligo(dT)(12-18). PCR primers were obtained as predeveloped assay reagents (TNF-
, IL-12, and
IFN-
; Perkin-Elmer) or were generated with Primer Express
version 1.5 software (Perkin-Elmer) and were ordered from Perkin-Elmer.
Whenever possible, primer pairs were designed to span intron-exon
borders. Samples were then subjected to 40 cycles of amplification at
95° for 15 s followed by 1 min at 60° using an ABI Geneamp
7700 Sequence Detection System (Perkin-Elmer) according to the
manufacturer's instructions. PCR amplification of the housekeeping
gene ubiquitin was performed for each sample to control for sample
loading and to allow normalization between samples according to
instructions by the manufacturer (Perkin-Elmer). Water controls were
included to ensure specificity. Each data point was examined for
integrity by analysis of the amplification plot. The
ubiquitin-normalized data were expressed as the fold induction of gene
expression in A. fumigatus-infected mice compared to
that in uninfected mice.
Interventional studies.
Endogenous intrapulmonary IL-18,
TNF-
, IL-12, and/or IFN-
activities were blocked by
pretreatment of the mice with cytokine-specific neutralizing MAbs.
Previous studies had demonstrated that responsiveness to IL-18 is
conferred by IL-18 binding to its cognate receptor, which consists
of the IL-R-related protein 1 chain (IL-1Rrp1, also known as
IL-1R5) and the IL-1R accessory protein-like chain (IL-1RAcPL, also known as IL-1R7 [4, 10, 48,
52]). Recent studies have also demonstrated that
IL-18-mediated cell activation could be prevented by inhibiting
IL-18 ligand receptor interaction, through administration of
anti-IL-18 antibody (31) or of MAbs which recognize
either the IL-1R5 chain (52) or the IL-1R7 chain (10) of the IL-18 receptor. Therefore, the following
cytokine-specific MAbs were used: anti-IL-18 receptor MAb
(anti-IL-18R MAb) directed towards the IL-1R7 chain of the
IL-18R (10), anti-IL-12 MAb (33),
anti-TNF-
MAb (22, 23), and anti-IFN-
MAb
(9). Each neutralizing MAb was administered
intraperitoneally at a dose of 1 mg of antibody/mouse, 2 h prior
to infection with A. fumigatus. Similarly infected mice
that were administered an isotype-matched immunoglobulin G1a (IgG1a) or
IgG2a served as controls.
Statistical analysis.
Analysis of variance was used to
compare differences between treatment groups. P values of
<0.05 were considered significant.
 |
RESULTS |
Pathogenesis of pulmonary A. fumigatus infection
in immunocompetent Crl:CF-1 mice.
The rate of A. fumigatus clearance from lungs of infected mice was
determined by culture of lung homogenates. Results of a representative
experiment (five mice per time point) are shown in Fig.
1. All mice survived the infection.
Approximately 6.0 × 106 organisms were recovered from
the lungs of mice 30 min after infection with A. fumigatus. There was no significant difference in recovery of
A. fumigatus over the first 12 h p.i. (hpi)
compared to that at 30 min p.i. At 24 to 168 hpi, A. fumigatus was gradually cleared from the lung, with detection of
approximately 10 CFU/lung at 7 days p.i. In agreement with previously
published studies (7, 14), these results demonstrate that
the innate immune response is sufficient to resolve primary
A. fumigatus pulmonary infections in immunocompetent
mice.

View larger version (59K):
[in this window]
[in a new window]
|
FIG. 1.
Temporal expression of immunoreactive cytokine activity
in BALF and growth of A. fumigatus in lungs of
immunocompetent Crl:CF-1 mice. Mice were infected with A. fumigatus as described in Materials and Methods. At specific times
p.i., mice were euthanatized and growth of A. fumigatus
was quantified in the lung homogenates by culture. Alternatively, the
lungs were lavaged and immunoreactive cytokine activity was quantified
in BALF by cytokine-specific ELISAs for IL-18, TNF- ,
IL-12p70, and IFN- . Results of a representative experiment
(n = 2) are shown and reflect the mean ± standard
error of the mean of five animals per time point. Symbol: *,
significantly greater than in uninfected mice, P < 0.05.
|
|
Temporal induction of cytokines in lungs of A. fumigatus-infected mice.
In order to gain insight as to the
potential role of IL-18 versus that of IL-12, TNF-
, and
IFN-
in the pathogenesis of pulmonary aspergillus infection,
temporal induction of immunoreactive cytokine activity was first
assessed in BALF and whole-lung homogenates of A. fumigatus-infected mice by using cytokine-specific ELISAs. Assessment of BALF (Fig. 1) and of lung homogenates (Fig.
2) allowed evaluation of both secreted
cytokine activity (i.e., into the intra-alveolar space) and total organ
activity, respectively. Results of these studies demonstrated that
IL-18 protein was significantly enhanced in BALF within 2 hpi, with
maximal induction at 4 hpi (Fig. 1a). In contrast, while IL-18
activity was constitutively expressed in lung homogenates from
uninfected mice (T = 0), it was not significantly
enhanced in lung homogenates from infected mice at any time p.i. (Fig.
2a). Induction of IL-18 in BALF preceded induction of TNF-
protein in BALF and lung homogenates (Fig. 1b and 2b), which was
apparent within 8 to 12 hpi, with maximal induction at 24 hpi.
Induction of both IL-18 and TNF-
preceded induction of
IL-12p70 and IFN-
proteins in BALF (Fig. 1c and d) and in
lung homogenates (Fig. 2c and d) at 24 to 48 and 48 to 72 hpi,
respectively. These studies also demonstrate that induction of
IL-18, TNF-
, IL-12, and IFN-
in BALF and/or in
lung homogenates was temporally correlated with clearance of
A. fumigatus from the lung.

View larger version (65K):
[in this window]
[in a new window]
|
FIG. 2.
Temporal expression of immunoreactive cytokine activity
in lung homogenates and growth of A. fumigatus in lungs
of immunocompetent Crl:CF-1 mice. Mice were infected with A. fumigatus. At specific times p.i., mice were euthanatized and
intrapulmonary growth of A. fumigatus was determined
(as described for Fig. 1). Alternatively, immunoreactive cytokine
activity was quantified in lung homogenates by cytokine-specific ELISAs
for IL-18, TNF- , IL-12p70, and IFN- . Results of a
representative experiment (n = 2) are shown and reflect
the mean ± standard error of the mean of five animals per time
point. Symbol: *, significantly greater than in uninfected mice,
P < 0.05.
|
|
In subsequent studies, temporal expression of IL-18, IL-12,
TNF-

, and IFN-

mRNAs in
A. fumigatus-infected lung tissue was
evaluated by real-time RT-PCR.
This method allows a rapid, accurate,
and precise quantitation of gene
transcripts (
19,
21). As
shown in Fig.
3, TNF-

(Fig.
3a), IL-12p40
(Fig.
3b), IL-12p35
(Fig.
3c), and IFN-

(Fig.
3d) mRNAs were
significantly enhanced
in the lungs of
A. fumigatus-infected mice at

4 hpi, with maximal
induction at 24 hpi. In contrast, IL-18 mRNA was constitutively
expressed and was
not significantly induced in the lung in response
to
A. fumigatus at any time assessed (data not shown). Also, induction
of TNF-

, IL-12p40, IL-12p35, and IFN-

mRNAs was
temporally correlated
with clearance of
A. fumigatus
from the lung (Fig.
3). Taken together,
these studies demonstrate that
in response to inhaled
A. fumigatus,
IL-18 protein
is induced rapidly in BALF, followed by induction
of TNF-

,
IL-12, and IFN-

proteins and mRNAs in infected BALF
and/or
lung tissue.

View larger version (63K):
[in this window]
[in a new window]
|
FIG. 3.
Temporal expression of cytokine mRNA and growth of
A. fumigatus in lungs of immunocompetent Crl:CF-1 mice.
Mice were infected with A. fumigatus as described in
Materials and Methods. At specific times p.i., mice were euthanatized
and intrapulmonary growth of A. fumigatus was
determined (as described for Fig. 1). Alternatively, the lungs were
excised and total RNA was extracted. Transcript levels were quantified
by real-time RT-PCR for TNF- , IL-12p40, IL-12p35, and
IFN- . Results of a representative experiment (n = 2) are shown and reflect the mean ± standard error of the
mean of five animals per time point. Symbol: *, significantly greater
than uninfected mice, P < 0.05.
|
|
Immunomodulatory activity of endogenous IL-18, TNF-
, and
IL-12 on cytokine activity in the lungs of A. fumigatus-infected mice.
In subsequent studies, the
relative immunomodulatory effect of IL-18, TNF-
, and
IL-12 on pulmonary cytokine activity in A. fumigatus-infected mice was determined. Immunocompetent mice were pretreated with IgG2a (control antibody), anti-IL-18R MAb
(10), anti-IL12 MAb (33), or anti-TNF-
MAb (22, 23) alone or in combination 2 h prior to
infection with A. fumigatus. The effect of cytokine
neutralization on TNF-
activity or on IL-12 and IFN-
activities too was assessed in lung homogenates at 24 and 48 hpi, respectively (i.e., when these cytokines were maximally induced in lung
homogenates of similarly infected immunocompetent mice [Fig. 2]). As
shown in Table 1, inhibition of
endogenous IL-18 and IL-12 in combination results in
significant inhibition (47%) of TNF-
at 24 hpi, when compared
to what was found in similarly infected mice that were administered a
control MAb. In contrast, inhibition of IL-18 or TNF-
activity did not result in significant inhibition of IL-12 at 48 hpi. However, inhibition of either IL-18, TNF-
, or IL-12
alone or of IL-12 and IL-18 together resulted in significant
inhibition (58, 50, 90, or 94%, respectively) of IFN-
in
infected lung tissue at 48 hpi. However, simultaneous inhibition of
both IL-18 and IL-12 did not result in significantly greater
inhibition of IFN-
than that caused by inhibition of either
cytokine alone. These results demonstrate that endogenous IL-18,
IL-12, and TNF-
play key, and in some cases potentially overlapping, roles in modulating cytokine activity in the lung in
response to inhaled A. fumigatus.
View this table:
[in this window]
[in a new window]
|
TABLE 1.
Modulation of intrapulmonary cytokine activity in
A. fumigatus-infected mice by endogenous IL-18,
TNF- , and IL-12a
|
|
Endogenous cytokines and resolution of primary A. fumigatus lung infection.
Because clearance of A. fumigatus from lungs of immunocompetent Crl:CF-1 mice is
temporally correlated with local induction of cytokines, including
IL-18, TNF-
, IL-12, and IFN-
(Fig. 1 to 3), the
biological relevance of each of these cytokines in the resolution of
pulmonary aspergillosis was assessed. Mice were administered
cytokine-specific neutralizing MAbs (anti-IL-18R MAb
[10], anti-TNF-
MAb [22, 23],
anti-IL-12 MAb [33]) or anti-IFN-
MAb
(9) (1 mg/mouse intraperitoneally) alone or in
combination 2 h prior to infection with A. fumigatus. At 24, 72, and 144 hpi, the mice were humanely
euthanatized and A. fumigatus CFU were quantified in
lung homogenates. Preliminary experiments had demonstrated that there
was no significant difference between recovery of A. fumigatus from lungs of mice treated with no antibody and recovery
from lungs of similarly infected mice administered a control antibody
(IgG1a or IgG2a) at all times studied (data not shown). Therefore,
intrapulmonary growth of A. fumigatus in mice
administered a cytokine-specific neutralizing MAb(s) was compared to
that found in similarly infected untreated mice (i.e., control mice).
Results of these studies demonstrated that at 24 hpi, there was no
significant difference between recovery of
A. fumigatus from lungs of mice administered anti-IL-18R MAb, anti-TNF-

MAb,
anti-IL-12 MAb, or anti-IFN-

MAb alone or in
combination and
recovery from lungs of similarly infected control mice
(data not
shown). In contrast, at 72 hpi, simultaneous neutralization
of
endogenous IL-12 activity and either IL-18 or TNF-

activity resulted
in a significant increase in
A. fumigatus CFU in infected lung
homogenates, as compared to
similarly infected control mice (Fig.
4a). At 144 hpi, inhibition of endogenous
TNF-

alone or in combination
with neutralization of other
cytokines, including IL-18, IL-12,
or IFN-

,
resulted in significantly enhanced recovery of
A. fumigatus from the lungs (Fig.
4b). However, there was no
significant difference
between recovery of
A. fumigatus from the lungs of mice treated
with an anti-TNF-

MAb alone and recovery from the lungs of mice
administered an
anti-TNF-

MAb in combination with these other
cytokine-specific
neutralizing MAbs. Simultaneous neutralization
of IL-12 and
IL-18 activity also resulted in a significant increase
in
A. fumigatus CFU in lung homogenates at 144 hpi. In
contrast,
inhibition of IFN-

activity did not result in a
significant increase
in
A. fumigatus in lung
homogenates at any time p.i. These results
demonstrate that
intrapulmonary cytokines, including TNF-

, IL-12,
and
IL-18, likely play critical roles in the clearance of
A. fumigatus from lungs of immunocompetent mice, while IFN-

may not play a
major role in host defense against primary pulmonary
aspergillosis
in this murine model system.

View larger version (39K):
[in this window]
[in a new window]
|
FIG. 4.
Role of endogenous IL-18, IL-12, TNF- ,
and IFN- in resolution of primary A. fumigatus
lung infection. Crl:CF-1 mice were administered anti-IL-18R MAb,
anti-TNF- MAb, anti-IL-12 MAb, and anti-IFN- MAb (1 mg/mouse intraperitoneally) alone or in combination 2 h prior to
infection with A. fumigatus. At 24, 72, and 144 hpi,
mice were euthanatized and their lungs were excised and homogenized.
Intrapulmonary growth of A. fumigatus was quantified by
culture of lung homogenates. Results of these studies demonstrated that
growth of A. fumigatus in the lung in mice treated with
cytokine-specific MAbs at 24 hpi was not significantly different from
growth in similarly infected, untreated mice (data not shown). In
contrast, significant differences in intrapulmonary growth of the
fungus were apparent in mice treated with cytokine-specific MAbs at 72 (a) and 144 (b) hpi, as compared to growth in similarly infected,
untreated mice. Results represent the pooled mean ± standard
error of the mean of two separate experiments, seven to nine animals
per treatment group. Symbol: *, significantly greater than similarly
infected control mice, P < 0.05.
|
|
 |
DISCUSSION |
Previous studies have suggested a directive role of Th1 cytokines
in leukocyte-mediated defense against primary pulmonary aspergillosis;
however, cytokine networking in the lung in response to A. fumigatus has not been thoroughly investigated. In this study, the
immunomodulatory role and biological relevance of endogenous cytokines,
including IL-18, TNF-
, IL-12, and IFN-
, in host
defense against primary A. fumigatus lung infection
were assessed in immunocompetent Crl:CF-1 mice infected with the
fungus. Results of our studies demonstrated that IL-18,
TNF-
, IL-12, and IFN-
proteins were induced
temporally (in this order) in the lung in response to inhaled
A. fumigatus. However, while induction of TNF-
,
IL-12, and IFN-
immunoreactive proteins was associated with
induction of the corresponding mRNAs, induction of immunoreactive
IL-18 in infected mice occurred in the absence of induction of
IL-18 mRNA. These results suggest that regulation of
intrapulmonary IL-18 protein expression during A. fumigatus infection occurred, at least in part, by a
posttranscriptional mechanism. IL-18 is synthesized as a precursor
molecule (pro-IL-18) devoid of a signal sequence and requires the
IL-1
converting enzyme (caspase 1) for cleavage into a mature
peptide (18, 20). The potential relationship between
intrapulmonary IL-1
converting enzyme activity and secretion of
mature IL-18 during A. fumigatus lung infection remains to be explored.
Temporal analysis of cytokine expression in the lungs of infected mice
demonstrated that induction of immunoreactive IL-18 in BALF
preceded induction of TNF-
, IL-12, and IFN-
proteins and corresponding mRNAs. IL-18 has previously been shown to have immunomodulatory effects on other cytokines, including TNF-
and IFN-
(30, 35). Furthermore, modulation of
IFN-
expression by IL-18 is due in large part to synergistic
effects of IL-18 with other cytokines, including IL-12
(1, 28, 30, 40, 53). Consequently, studies using
cytokine-specific neutralizing MAbs were conducted to assess
immunomodulatory effects of endogenous IL-18, TNF-
, and
IL-12 on intrapulmonary cytokine activity in infected mice. Results
of these studies (Table 1) demonstrated that IL-18 and IL-12
together regulated intrapulmonary TNF-
activity, while
IL-18, TNF-
, and IL-12 regulated IFN-
activity.
These results demonstrate that IL-18, TNF-
, and IL-12
are key modulators of intrapulmonary cytokine activity during
A. fumigatus lung infection.
Subsequent studies using cytokine-specific neutralizing antibodies were
conducted to identify the potential biological relevance of endogenous
IL-18, IL-12, TNF-
, and IFN-
in host defense
against pulmonary aspergillosis. Results of these studies (Fig. 4)
demonstrated that IL-12 and IL-18 acted synergistically to
facilitate resolution of A. fumigatus pulmonary
infection in the immunocompetent host, as simultaneous inhibition of
both cytokines but not of either cytokine alone resulted in the
enhanced recovery of A. fumigatus from infected lung
tissue. The mechanism by which IL-12 and IL-18 mediate the
clearance of A. fumigatus from the lungs of
immunocompetent Crl:CF-1 mice remains to be explored. Our results
suggest that it occurs largely by an IFN-
-independent mechanism,
since inhibition of endogenous IFN-
alone did not significantly
alter clearance of A. fumigatus from the lung. Results
of our in vivo studies are in agreement with those of a recent in vitro
study which showed that IL-12-induced fungicidal activity of
cultured human mononuclear phagocytes against A. fumigatus occurred by means of an IFN-
-independent mechanism (43). In addition to modulating IFN-
activity, IL-12 and IL-18 have pleiotropic effects, which
include regulation of NK cell cytotoxicity (24, 39). The
potential role of cytotoxic NK cells in resistance to primary
A. fumigatus lung infection remains to be thoroughly investigated.
Results of our study contrast with those of a previous study, which
demonstrated that inhibition of IL-12 alone resulted in enhanced
intrapulmonary growth of A. fumigatus in experimentally infected BALB/c mice (8). While the reason for the
disparity between results of these two studies is not completely
understood, it is likely due, in part, to differences in A. fumigatus strains, inoculum doses, and/or murine strains (i.e.,
susceptible [BALB/c] versus resistant [Cr:CF1]) used.
In addition, inhibition of TNF-
, either alone or in combination
with inhibition of other cytokines, including IL-12, IL-18, and
IFN-
, also resulted in significantly delayed clearance of A. fumigatus from the lung (Fig. 4). These results
confirm those of earlier studies (27) and suggest that
endogenous TNF-
plays a key role in host resistance to
A. fumigatus pulmonary infection. TNF-
likely
contributes to host defense against A. fumigatus by
means of several mechanisms. Although not directly chemotactic for
phagocytic cells, TNF-
induces leukocyte and endothelial cell
expression of adhesion molecules, thus influencing phagocytic cell
trafficking in the lungs (17, 27). In addition,
TNF-
modulates chemokine expression, thereby modulating both the
influx and activation of phagocytic cells in the lung
(27).
In summary, using a murine model of A. fumigatus
pulmonary infection in immunocompetent mice, we have demonstrated that
proinflammatory cytokines, including IL-18, TNF-
, and
IL-12, play key roles in host defense against pulmonary
aspergillosis in the immunocompetent host, due to their effects on both
local cytokine activity and clearance of A. fumigatus
from the lung. These studies are the first to identify the potential
role of IL-18 in innate immunity to pulmonary aspergillosis and to
characterize immunomodulatory effects of IL-18 on intrapulmonary
cytokine activity during A. fumigatus lung infection.
Future studies which elucidate the role of endogenous cytokines in
resistance to A. fumigatus lung infection are
warranted, as they may provide new strategies for adjunct therapy for
prevention and treatment of invasive pulmonary aspergillosis in
immunocompromised patients.
 |
ACKNOWLEDGMENTS |
We thank Ferous Gheyas and Steven Novick from the Biostatistics
Department at Schering Plough Research Institute for their assistance
with analysis of the data. We also thank Frank Sabatelli from the
Infectious Disease Department at Schering Plough Research Institute for
his assistance with graphics.
 |
FOOTNOTES |
*
Corresponding author. Mailing address: Schering Plough
Research Institute, 2015 Galloping Hill Rd., K15-B432 4800, Kenilworth, NJ 07033. Phone: (908) 740-3147. Fax: (908) 740-3918. E-mail: joan.brieland{at}spcorp.com.
Editor:
W. A. Petri Jr.
 |
REFERENCES |
| 1.
|
Ahn, H. J.,
S. Maruo,
M. Tomura,
J. Mu,
T. Hamaoka,
K. Nakanishi,
S. Clark,
M. Kurimoto,
H. Okamura, and H. Fujiwara.
1997.
A mechanism underlying synergy between IL-12 and IFN-gamma-inducing factor in enhanced production of IFN-gamma.
J. Immunol.
159:2125-2131[Abstract/Free Full Text].
|
| 2.
|
Berenguer, J.,
M. C. Allende,
J. W. Lee,
K. Garrett,
C. Lyman,
N. M. Ali,
J. Bacher,
P. A. Pizzo, and T. J. Walsh.
1995.
Pathogenesis of pulmonary aspergillosis. Granulocytopenia versus cyclosporine and methylprednisolone-induced immunosuppression.
Am. J. Respir. Crit. Care Med.
152:1079-1086[Abstract].
|
| 3.
|
Blanchard, D. K.,
J. Y. Djeu,
T. W. Klein,
H. Friedman,
W. E. Steward II, and E. W. Stewart.
1988.
Protective effects of tumor necrosis factor in experimental Legionella pneumophila infections of mice via activation of PMN function.
J. Leukoc. Biol.
43:429-435[Abstract].
|
| 4.
|
Born, T. L.,
E. Thomassen,
T. A. Bird, and J. E. Sims.
1998.
Cloning of a novel receptor subunit, AcPL, required for interleukin-18 signaling.
J. Biol. Chem.
273:29445-29450[Abstract/Free Full Text].
|
| 5.
|
Cenci, E.,
A. Mencacci,
C. Fe d'Ostiani,
C. Montagnoli,
A. Bacci,
G. Del Sero,
S. Perito,
F. Bistoni, and L. Romani.
1998.
Cytokine and T-helper-dependent immunity in murine aspergillosis.
Res. Immunol.
149:445-454[CrossRef][Medline].
|
| 6.
|
Cenci, E.,
A. Mencacci,
C. Fe d'Ostiani,
G. Del Sero,
P. Mosci,
C. Montagnoli,
A. Bacci, and L. Romani.
1998.
Cytokine and T helper-dependent lung mucosal immunity in mice with invasive pulmonary aspergillosis.
J. Infect. Dis.
178:1750-1760[CrossRef][Medline].
|
| 7.
|
Cenci, E.,
S. Perito,
K. H. Enssle,
P. Mosci,
J. P. Latge,
L. Romani, and F. Bistoni.
1997.
Th1 and Th2 cytokines in mice with invasive aspergillosis.
Infect. Immun.
65:564-570[Abstract].
|
| 8.
|
Cenci, E.,
A. Mencacci,
G. Del Sero,
A. Bacci,
C. Montagnoli,
C. Fe d'Ostiani,
P. Mosci,
M. Bachmann,
F. Bistoni,
M. Kopf, and L. Romani.
1999.
Interleukin-4 causes susceptibility in invasive pulmonary aspergillosis through suppression of protective type 1 responses.
J. Infect. Dis.
180:1957-1968[CrossRef][Medline].
|
| 9.
|
Cherwinski, H. M.,
J. H. Schumacher,
K. D. Brown, and T. R. Mosmann.
1987.
Two types of mouse helper T cell clone. III. Further differences in lymphokine synthesis between Th1 and Th2 clones revealed by RNA hybridization, functionally monospecific bioassays, and monoclonal antibodies.
J. Exp. Med.
166:1229-1244[Abstract/Free Full Text].
|
| 10.
|
Debets, R.,
J. C. Timans,
T. Churakowa,
S. Zurawski,
R. de Waal Malefyt,
K. W. Moore,
J. S. Abrams,
A. O'Garra,
J. F. Bazan, and R. A. Kastelein.
2000.
IL-18 receptors, their role in ligand binding and function: anti-IL-18RAcPL antibody, a potent antagonist of IL-18.
J. Immunol.
165:4950-4956[Abstract/Free Full Text].
|
| 11.
|
De Repentigny, L.,
S. Petitbois,
M. Boushira,
E. Michaliszyn,
S. Senechal,
N. Gendron, and S. Montplaisir.
1993.
Acquired immunity in experimental murine aspergillosis is mediated by macrophages.
Infect. Immun.
61:3791-3802[Abstract/Free Full Text].
|
| 12.
|
Diamond, R. D.,
R. Krzesicki,
B. Epstein, and J. Jao.
1978.
Damage to hyphal forms of fungi by human leukocytes in vitro: a possible host defense mechanism in aspergillosis and mucormycosis.
Am J. Pathol.
91:313-328[Abstract].
|
| 13.
|
Diamond, R. D., and R. A. Clark.
1982.
Damage to Aspergillus fumigatus and Rhizopus oryzae hyphae by oxidative and nonoxidative microbicidal production of human neutrophils in vitro.
Infect. Immun.
38:487-495[Abstract/Free Full Text].
|
| 14.
|
Dixon, D. M.,
A. Polak, and T. J. Walsh.
1989.
Fungus dose-dependent primary pulmonary aspergillosis in immunosuppressed mice.
Infect. Immun.
75:1452-1456.
|
| 15.
|
Djeu, J. Y.
1993.
Modulators of immune responses to fungi, p. 521-532.
In
J. W. Murphy, H. Friedman, and M. Bendinelli (ed.), Fungal infections and immune responses. Plenum Press, New York, N.Y.
|
| 16.
|
Duong, M.,
N. Ouellet,
M. Simard,
Y. Bergeron,
M. Olivier, and M. G. Bergeron.
1998.
Kinetic study of host defense and inflammatory response to Aspergillus fumigatus in steroid-induced immunosuppressed mice.
J. Infect. Dis.
178:1472-1482[CrossRef][Medline].
|
| 17.
|
Gamble, J. R.,
J. M. Harlan,
S. J. Klebanoff, and M. A. Vadas.
1985.
Stimulation of the adherence of neutrophils to umbilical vein endothelium by human recombinant tumor necrosis factor.
Proc. Natl. Acad. Sci. USA
82:8667-8671[Abstract/Free Full Text].
|
| 18.
|
Ghayur, T.,
S. Banerjee,
M. Hugunin,
D. Butler,
L. Herzog,
A. Carter,
L. Quintal,
L. Sekut,
R. Talanian,
M. Paskind,
W. Wong,
R. Kamen,
D. Tracey, and H. Allen.
1997.
Caspase-1 processes IFN-gamma inducing factor and regulates LPS-induced IFN- production.
Nature
386:619-623[CrossRef][Medline].
|
| 19.
|
Gibson, U. E.,
C. A. Heid, and P. M. Williams.
1996.
A novel method for real time quantitative RT-PCR.
Genome Res.
6:995-1001[Abstract/Free Full Text].
|
| 20.
|
Gu, Y.,
K. Kuida,
H. Tsutsui,
G. Ku,
K. Hsiao,
M. A. Fleming,
N. Hayashi,
K. Higashino,
H. Okamura,
K. Nakanishi,
M. Kurimoto,
T. Tanimoto,
R. A. Flavell,
V. Sato,
M. W. Harding,
D. J. Livingston, and M. S. Su.
1997.
Activation of interferon- inducing factor, mediated by interleukin-1B converting enzyme.
Science
275:206-209[Abstract/Free Full Text].
|
| 21.
|
Heid, C. A.,
J. Stevens,
K. J. Livak, and P. M. Williams.
1996.
Real time quantitative PCR.
Genome Res.
6:986-994[Abstract/Free Full Text].
|
| 22.
|
Hernandez-Caselles, T., and O. Stutman.
1993.
Immune functions of tumor necrosis factor. I. Tumor necrosis factor induces apoptosis of mouse thymocytes and can also stimulate or inhibit IL-6-induced proliferation depending on the concentration of mitogenic costimulation.
J. Immunol.
151:3999-4012[Abstract].
|
| 23.
|
Hunter, C. A.,
J. S. Abrams,
M. H. Beaman, and J. S. Remington.
1993.
Cytokine mRNA in the central nervous system of SCID mice infected with Toxoplasma gondii: importance of T-cell-independent regulation of resistance to T. gondii.
Infect. Immun.
61:4038-4044[Abstract/Free Full Text].
|
| 24.
|
Hyodo, Y.,
K. Matsui,
N. Hayashi,
H. Tsutsui,
S. Kashiwamura,
H. Yamauchi,
K. Hiroishi,
K. Takeda,
Y. Tagawa,
Y. Iwakura,
N. Kayagaki,
M. Kuimoto,
H. Okamura,
T. Hada,
H. Yagita,
S. Akira,
K. Nakanishi, and K. Higashino.
1999.
IL-18 up-regulates perforin-mediated NK activity without increasing perforin messenger RNA expression by binding to constitutively expressed IL-18 receptor.
J. Immunol.
162:1662-1668[Abstract/Free Full Text].
|
| 25.
|
Levitz, S. M.,
M. E. Selsted,
T. Ganz,
R. I. Lehrer, and R. D. Diamond.
1986.
In vitro killing of spores and hyphae of Aspergillus fumigatus and Rhizopus oryzae by rabbit neutrophil cationic peptides and bronchoalveolar macrophages.
J. Infect. Dis.
154:483-489[Medline].
|
| 26.
|
Loebenberg, D.,
A. Cacciapuoti,
R. Parmegiani,
E. L. Moss, Jr.,
F. Menzel, Jr.,
B. Antonoacci,
C. Norris,
T. Yarosh-Tomaine,
R. S. Hare, and G. H. Miller.
1992.
In vitro and in vivo activities of SCH 42427, the active anantiomer of the antifungal agent SCH 39304.
Antimicrob. Agents Chemother.
36:498-501[Abstract/Free Full Text].
|
| 27.
|
Mehrad, B.,
R. M. Strieter, and T. J. Standiford.
1999.
Role of TNF- in pulmonary host defense in murine invasive aspergillosis.
J. Immunol.
162:1633-1640[Abstract/Free Full Text].
|
| 28.
|
Micallef, M. J.,
T. Ohtsuki,
K. Kohno,
F. Tanabe,
S. Ushio,
M. Namba,
T. Tanimoto,
K. Torigoe,
M. Fujii,
M. Ikeda,
S. Fukuda, and M. Kurimoto.
1996.
Interferon- -inducing factor enhances T helper 1 cytokine production by stimulated human T cells: synergism with interleukin-12 for interferon- production.
Eur. J. Immunol.
26:1647-1651[Medline].
|
| 29.
|
Nagai, H.,
J. Guo,
H. Choi, and V. Kurup.
1995.
Interferon- and tumor necrosis factor- protect mice from invasive aspergillosis.
J. Infect. Dis.
172:1554-1560[Medline].
|
| 30.
|
Okamura, H.,
S. Kashiwamura,
H. Tsutsui,
T. Yoshimoto, and K. Nakanishi.
1998.
Regulation of interferon- production by IL-12 and IL-18.
Curr. Opin. Immunol.
10:259-264[CrossRef][Medline].
|
| 31.
|
Okamura, H.,
H. Tsutsui,
T. Komatsu,
M. Yatsudo,
A. Hakura,
T. Tanimoto,
K. Torigoe,
T. Okura,
Y. Nukada,
K. Hattori,
K. Akita,
M. Namba,
F. Tanabe,
K. Knoishi,
S. Fukuda, and M. Kurimoto.
1995.
Cloning of a new cytokine that induces IFN- production by T cells.
Nature
378:88-91[CrossRef][Medline].
|
| 32.
|
Okamura, H.,
K. Nagata,
T. Komatsu,
T. Tanimoto,
T. Nukata,
Y. Tanabe,
K. Akita,
K. Torigoe,
T. Okura, and S. Fukuda.
1995.
A novel costimulatory factor for gamma interferon induction found in the livers of mice causes endotoxic shock.
Infect. Immun.
63:3966-3972[Abstract].
|
| 33.
|
Ozmen, L.,
M. Pericin,
J. Hakimi,
R. A. Chizzonite,
M. Wysocka,
G. Trinchieri,
M. Tagely, and G. Garotta.
1994.
Interleukin 12, interferon gamma, and tumor necrosis factor alpha are the key cytokines of the generalized Shwartzman reaction.
J. Exp. Med.
180:907-915[Abstract/Free Full Text].
|
| 34.
|
Piggot, W. R., and C. W. Emmons.
1960.
Device for inhalation exposure of animals to spores.
Proc. Soc. Exp. Biol. Med.
103:805-806.
|
| 35.
|
Puren, A.,
G. Fantuzzi,
Y. Gu,
M. Su, and C. Dinarello.
1998.
Interleukin-18 (IFN- -inducing factor) induces IL-8 and IL-1B via TNF- production from non-CD14+ human blood mononuclear cells.
J. Clin. Investig.
101:711-721[Medline].
|
| 36.
|
Qureshi, M. H.,
T. Ahang,
Y. Koguchi,
K. Nakashima,
H. Okamura,
N. Kurimoto, and K. Kawakami.
1999.
Combined effects of IL-12 and IL-18 on the clinical course and local cytokine production in murine pulmonary infection with Cryptococcus neoformans.
Eur. J. Immunol.
29:643-649[CrossRef][Medline].
|
| 37.
|
Rex, J. H.,
J. E. Bennett,
J. I. Galin,
H. L. Malech,
E. S. Decarlo, and D. A. Melnick.
1991.
In vivo interferon- augments in vitro ability of chronic granulomatous disease neutrophils to damage Aspergillus hyphae.
J. Infect. Dis.
163:849-852[Medline].
|
| 38.
|
Rhodes, J. C.
1993.
Aspergillosis, p. 359-377.
In
T. W. Murphy, H. Friedman, and M. Bendinelli (ed.), Fungal infections and immune responses. Plenum Press, New York, N.Y.
|
| 39.
|
Robertson, M. J.,
R. J. Soiffer,
S. F. Wolf,
T. J. Manley,
C. Donahue,
D. Young,
S. H. Herrmann, and J. Ritz.
1992.
Response of human natural killer cells to NK cell stimulatory factor (NKSF): cytolytic activity and proliferation of NK cells are differentially regulated by NKSF.
J. Exp. Med.
175:779-788[Abstract/Free Full Text].
|
| 40.
|
Robinson, D.,
K. Shibuya,
A. Mui,
F. Zonin,
E. Murphy,
T. Sana,
S. B. Hartley,
S. Menon,
R. Kastelein,
F. Bazan, and A. O'Garra.
1997.
IGIF does not drive Th1 development but synergizes with IL-12 for interferon- production and activates IRAK and NF B.
Immunity
7:571-581[CrossRef][Medline].
|
| 41.
|
Roilides, E.,
A. Dimitriadou,
I. Kadiltsoglou,
T. Sein,
J. Karpouzas,
P. A. Pizzo, and T. J. Walsh.
1997.
IL-10 exerts suppressive and enhancing effects on antifungal activity of mononuclear phagocytes against Aspergillus fumigatus.
J. Immunol.
158:322-329[Abstract].
|
| 42.
|
Roilides, E.,
K. Uhlig,
D. Venzon,
P. A. Pizzo, and T. J. Walsh.
1993.
Enhancement of oxidative response and damage caused by human neutrophils to Aspergillus fumigatus hyphae by granulocyte colony-stimulating factor and gamma interferon.
Infect. Immun.
61:1185-1193[Abstract/Free Full Text].
|
| 43.
|
Roilides, E.,
S. Tsaparidou,
I. Kadiltsoglou,
T. Sein, and T. J. Walsh.
1999.
Interleukin-12 enhances antifungal activity of human mononuclear phagocytes against Aspergillus fumigatus: implications for a gamma interferon-independent pathway.
Infect. Immun.
67:3047-3050[Abstract/Free Full Text].
|
| 44.
|
Roilides, E.,
H. Katsifa, and T. J. Walsh.
1998.
Pulmonary host defenses against Aspergillus fumigatus.
Res. Immunol.
149:454-465[CrossRef][Medline].
|
| 45.
|
Schaffner, A.,
H. Douglas, and A. Braude.
1982.
Selective protection against conidia by mononuclear and against mycelia by polymorphonuclear phagocytes in resistance to Aspergillus. Observations on these two lines of defense in vivo and in vitro with human and mouse phagocytes.
J. Clin. Investig.
69:617-631.
|
| 46.
|
Sugawara, I.,
H. Yamada,
H. Kaneko,
S. Mizuno,
K. Takeda, and S. Akira.
1999.
Role of interleukin-18 (IL-18) in mycobacterial infection in IL-18-gene-disrupted mice.
Infect. Immun.
67:2585-2589[Abstract/Free Full Text].
|
| 47.
|
Tomura, M.,
X. Y. Zhou,
S. Maruo,
H. J. Ahn,
T. Hamaoka,
H. Okamura,
K. Nakanishi,
T. Tanimoto,
M. Kurimoto, and H. Fujiwara.
1998.
A critical role for IL-18 in proliferation and activation of NK1.1+ CD3 cells.
J. Immunol.
160:4730-4746[Abstract/Free Full Text].
|
| 48.
|
Torigoe, I.,
S. Ushio,
T. Okura,
S. Kobayashi,
M. Taniai,
T. Kunikata,
T. Murakami,
O. Sanou,
H. Kojima,
M. Fujii,
T. Ohta,
M. Ikeda,
H. Ikegami, and M. Kurimoto.
1997.
Purification and characterization of the human interleukin-18 receptor.
J. Biol. Chem.
272:25737-25742[Abstract/Free Full Text].
|
| 49.
|
Waldorf, A. R.,
S. M. Levitz, and R. D. Diamond.
1984.
In vivo bronchoalveolar macrophage defense against Rhizophus oryzae and Aspergillus fumigatus.
J. Infect. Dis.
150:752-760[Medline].
|
| 50.
|
Walsh, T.
1990.
Invasive aspergillosis in patients with neoplastic diseases.
Semin. Respir. Infect.
5:111-122[Medline].
|
| 51.
|
Weinberger, M.,
D. Elattar,
D. Marshall,
S. M. Steinberg,
R. L. Redner,
N. S. Young, and P. A. Pizzo.
1992.
Patterns of infection in patients with aplastic anemia and the emergence of Aspergillus as a major cause of death.
Medicine
71:24-43[Medline].
|
| 52.
|
Xu, D.,
W. L. Chan,
B. P. Leung,
D. Hunter,
K. Schulz,
R. W. Carter,
I. B. McInnes,
J. H. Robinson, and F. Y. Liew.
1998.
Selective expression and functions of interleukin 18 receptor on T helper (Th) type 1 but not Th2 cells.
J. Exp. Med.
188:1485-1492[Abstract/Free Full Text].
|
| 53.
|
Yoshimoto, T.,
K. Takeda,
T. Tanaka,
K. Ohkusu,
S. Kashiwamura,
H. Okamura,
S. Akira, and K. Nakanishi.
1998.
IL-12 up-regulates IL-18 receptor expression on T cells, Th1 cells and B cells: synergism with IL-18 for IFN- production.
J. Immunol.
161:3400-3407[Abstract/Free Full Text].
|
Infection and Immunity, March 2001, p. 1554-1560, Vol. 69, No. 3
0019-9567/01/$04.00+0 DOI: 10.1128/IAI.69.3.1554-1560.2001
Copyright © 2001, American Society for Microbiology. All rights reserved.
This article has been cited by other articles:
-
Rivera, A., Collins, N., Stephan, M. T., Lipuma, L., Leiner, I., Pamer, E. G.
(2009). Aberrant Tissue Localization of Fungus-Specific CD4+ T Cells in IL-10-Deficient Mice. J. Immunol.
183: 631-641
[Abstract]
[Full Text]
-
Park, S. J., Hughes, M. A., Burdick, M., Strieter, R. M., Mehrad, B.
(2009). Early NK Cell-Derived IFN-{gamma} Is Essential to Host Defense in Neutropenic Invasive Aspergillosis. J. Immunol.
182: 4306-4312
[Abstract]
[Full Text]
-
Tsiodras, S., Samonis, G., Boumpas, D. T., Kontoyiannis, D. P.
(2008). Fungal Infections Complicating Tumor Necrosis Factor {alpha} Blockade Therapy. Mayo Clin Proc.
83: 181-194
[Abstract]
[Full Text]
-
Simitsopoulou, M., Roilides, E., Likartsis, C., Ioannidis, J., Orfanou, A., Paliogianni, F., Walsh, T. J.
(2007). Expression of Immunomodulatory Genes in Human Monocytes Induced by Voriconazole in the Presence of Aspergillus fumigatus. Antimicrob. Agents Chemother.
51: 1048-1054
[Abstract]
[Full Text]
-
Lean, I-S., Lacroix-Lamande, S., Laurent, F., McDonald, V.
(2006). Role of Tumor Necrosis Factor Alpha in Development of Immunity against Cryptosporidium parvum Infection. Infect. Immun.
74: 4379-4382
[Abstract]
[Full Text]
-
Herring, A. C., Falkowski, N. R., Chen, G.-H., McDonald, R. A., Toews, G. B., Huffnagle, G. B.
(2005). Transient Neutralization of Tumor Necrosis Factor Alpha Can Produce a Chronic Fungal Infection in an Immunocompetent Host: Potential Role of Immature Dendritic Cells. Infect. Immun.
73: 39-49
[Abstract]
[Full Text]
-
Stephens-Romero, S. D., Mednick, A. J., Feldmesser, M.
(2005). The Pathogenesis of Fatal Outcome in Murine Pulmonary Aspergillosis Depends on the Neutrophil Depletion Strategy. Infect. Immun.
73: 114-125
[Abstract]
[Full Text]
-
Balloy, V., Huerre, M., Latge, J.-P., Chignard, M.
(2005). Differences in Patterns of Infection and Inflammation for Corticosteroid Treatment and Chemotherapy in Experimental Invasive Pulmonary Aspergillosis. Infect. Immun.
73: 494-503
[Abstract]
[Full Text]
-
Halpern, M. D., Holubec, H., Dominguez, J. A., Meza, Y. G., Williams, C. S., Ruth, M. C., McCuskey, R. S., Dvorak, B.
(2003). Hepatic inflammatory mediators contribute to intestinal damage in necrotizing enterocolitis. Am. J. Physiol. Gastrointest. Liver Physiol.
284: G695-G702
[Abstract]
[Full Text]
-
Mehrad, B., Wiekowski, M., Morrison, B. E., Chen, S.-C., Coronel, E. C., Manfra, D. J., Lira, S. A.
(2002). Transient Lung-Specific Expression of the Chemokine KC Improves Outcome in Invasive Aspergillosis. Am. J. Respir. Crit. Care Med.
166: 1263-1268
[Abstract]
[Full Text]
-
Reddy, P., Teshima, T., Hildebrandt, G., Duffner, U., Maeda, Y., Cooke, K. R., Ferrara, J. L. M.
(2002). Interleukin 18 preserves a perforin-dependent graft-versus-leukemia effect after allogeneic bone marrow transplantation. Blood
100: 3429-3431
[Abstract]
[Full Text]
-
Mambula, S. S., Sau, K., Henneke, P., Golenbock, D. T., Levitz, S. M.
(2002). Toll-like Receptor (TLR) Signaling in Response to Aspergillus fumigatus. J. Biol. Chem.
277: 39320-39326
[Abstract]
[Full Text]
-
Foxman, E. F., Zhang, M., Hurst, S. D., Muchamuel, T., Shen, D., Wawrousek, E. F., Chan, C.-C., Gery, I.
(2002). Inflammatory Mediators in Uveitis: Differential Induction of Cytokines and Chemokines in Th1- Versus Th2-Mediated Ocular Inflammation. J. Immunol.
168: 2483-2492
[Abstract]
[Full Text]